INTRODUCTION
The lung is one of the most fascinating and intricate immunological sites of the human body. The lower respiratory tract is covered with a 75 m 2 monolayer of epithelial cells that separate the outside world from the underlying vasculature and protect the interstitial tissue. Although the lungs are constantly exposed to pollutants and airborne microbes, pathogens seldom manage to cause disease, as most are met with appropriate local immune responses. Once elicited, respiratory infections and ensuing immune responses can have severe consequences for the vital gas exchange. Therefore, the balance between immune protection and prevention of immunopathology must be carefully regulated.
Annually, respiratory viruses are a major cause of morbidity and mortality worldwide, especially among the young, elderly, and immunocompromised individuals. Despite reports demonstrating a role of lung CD4 þ T cells in protecting against airborne infections, 1-3 their characteristics and mode of action remain to be determined. Significant numbers of CD4 þ T cells, even outnumbering CD8
þ T cells, were demonstrated to be present in the lungs of healthy individuals. 4 It is unclear whether lung CD4 þ T cells predominantly mediate helper functions by engaging local B cells and supporting CD8 þ T cells or whether they locally execute immune effector functions. In fact, lung CD4 þ T cells could be functionally multifaceted as they were shown, in mouse infection models, to drive recruitment of other immune effectors to the inflamed site 1 and promote development of protective resident CD8 þ CD103 þ T cells in the lung epithelium. 5 To what extent similar mechanisms operate in human lungs remains unclear.
Upon pathogen encounter naive T (T N ) cells can differentiate into several types of memory T cells. These memory subtypes can be phenotypically separated into central memory (T CM ), effector memory (T EM ), and resident memory (T RM ) T cells. [6] [7] [8] [9] Whereas T EM and T CM migrate almost exclusively through blood and lymphoid tissue, T RM are restricted to nonlymphoid tissues, such as the lungs, 1, 5, [10] [11] [12] [13] brain, 14, 15 skin, 16, 17 and vaginal mucosa. 18, 19 T RM can be defined by the expression of CD69, an inhibitor of S1PR1 function, that prevents cells from exiting the tissue. 20 Further, downregulation of S1PR1 is necessary for the establishment of CD8 þ T RM . 21 Epithelial T RM can in addition be defined by the expression of CD103, the a E subunit of the a E b 7 integrin that is required to dock these cells to the E-cadherin-expressing epithelial cells. 22, 23 This interaction may be crucial for T RM barrier function, as it retains the T RM at the entry site of pathogens, thus allowing for their fast recognition. This notion is corroborated by the enrichment of respiratory virus-specific CD8 þ T cells in the CD103 þ fraction of the human lung. 11 Although murine CD4 þ T RM express similar surface molecules as CD8 þ T RM , 2,10 their precise characteristics and molecular imprints are not as well defined. Nevertheless there are several indications pointing toward the important role of CD4 þ T RM in protection against respiratory infections. CD4 þ T cells are necessary for the formation of protective CD8 þ T RM during primary influenza infection. 5 This function would be in line with traditional helper cell function described for CD4 þ T cells. [24] [25] [26] [27] [28] [29] In addition, lung CD4 þ T RM themselves protect against lethal influenza challenge, whereas spleen CD4 þ T cells do not. 2 The precise mechanism(s) for direct effector functions executed by CD4 þ lung T RM are ill defined, although several reports point toward a helper-independent function operated by interferon-g (IFNg) 1, 3 and cytotoxic molecules.
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Here we analyzed the genetic program of CD4 þ CD103 þ T cells obtained from human lungs. By determining the minimal core transcriptional signature, we demonstrated that lung CD4 þ
CD103
þ T cells represent a unique subset of CD4 þ T cells that are very different from blood CD4 þ T cells but closely related to lung CD8 þ CD103 þ T RM . 13 In contrast to what was previously demonstrated for CD4 þ memory T cells in the skin, 30, 31 our data suggest that CD4 þ CD103 þ T cells from the lung represent a genuine resident population that is unlikely to equilibrate with the circulation. We identified a set of chemokine receptors and adhesion molecules that allow CD4 þ T RM to migrate and persist in the lungs. Furthermore, lung CD4 þ CD103 þ T RM constitutively expressed mRNA encoding various effector molecules and produced multiple cytokines upon stimulation. The magnitude of this response was not only more robust than that of circulating CD4 þ T-cell subsets, but also faster and highly polyfunctional. Our findings suggest that targeting the generation of CD4 þ T RM in the lung would be an attractive approach for future vaccine strategies and immunotherapies.
RESULTS

Lung CD4
þ T RM are phenotypically distinct from circulating CD4 þ T cells
We found that CD4 þ T cells were abundantly present in human lungs of patients undergoing partial lung resection, and at similar frequencies as in paired blood (Figure 1a) . To identify CD4 þ T RM in human lung tissue, we analyzed the surface expression of CD103 and CD69 on CD4 þ T cells in these samples. Lung, but not paired blood, CD4
þ T cells could be divided into three populations based on the expression of CD69 and CD103 (Figure 1b and Supplementary Figure S1 online). The most abundant population in the lung was CD103 À
CD69
þ that represented 50% of total CD4 þ T cells (Figure 1c) . The expression of CD103 varied among the patients, as 10 to 60% (average 20%) of lung CD4 þ T cells were CD103 þ CD69 þ . In parallel, we determined the differentiation stage of lung CD4 þ T cells by evaluating the surface expression of CD27 and CD45RA (Figure 1d, (Figure 1g) .
On average, 20% of the lung CD4 þ T cells expressed neither CD69 nor CD103 (Figure 1c) . Although we currently do not have ways to distinguish the potential T RM from the circulating T cells in humans, it should be noted that based on the low expression of CD28 it is unlikely that the majority of these cells belong to the circulating pool. For the remainder of the study we focused on the analysis of the epithelium-dwelling CD103 þ CD69 þ fractions and use CD103 À CD69 þ T cells and blood-derived CD4 þ T-cell subsets as a comparison. We will refer to lung CD4
To determine the gene expression profile of lung CD4 þ T RM , we isolated mRNA from CD4 þ CD103 þ T cells directly after isolation and performed microarray analysis. The lung CD4 þ CD103 þ T RM gene expression profile was compared with peripheral blood CD4 þ T-cell subsets to decipher a T RM core signature. CD103 þ T RM were sorted from noncancerous lobectomy tissues of five patients with non-small-cell lung carcinoma and simultaneously peripheral bloodderived memory and naive CD4 þ T-cell populations were sorted from five healthy donors. The core lung CD103 þ T RM signature was identified by comparing the transcriptome of CD103 þ T RM with that of blood T EM (CD45RA Table S1 ). In accordance with their predominant CD45RA À CD27 À phenotype, the CD103 þ T RM transcriptional profile proved most similar to the profile of 
À , and total blood CD4 þ T cells. (f,g) The expression of CCR7 (f) and CD28 (g) was quantified as percentage on lung CD4
The histogram overlays (maximum set to 100%) show the expression of CCR7 (f) and CD28 (g) on a representative lung CD4 peripheral blood T EM , followed by T M and T N with 649, 1,178, and 2,438 genes differentially expressed, respectively.
Human lung CD4 þ CD103 þ T RM expressed high transcript levels of ITGAE, CTLA4, and ICOS. On the other side, the expression of S1PR1, and the lymph node-homing molecules, SELL and CCR7, was low (Figure 2b) , suggesting that the CD4 þ CD103 þ T RM are retained in the tissue and unlikely recirculate. A similar trend was observed for KLF2 (Supplementary Figure S2 ) that drives expression of S1PR1. We validated a number of these genes by quantitative PCR (Supplementary Figure S2 ). Among the 100 most differentially expressed genes between CD103
þ T RM and peripheral T EM cells were genes encoding for transcription factors mediating effector T-cell differentiation and function (ERG2, EPAS1, and BATF), solute carrier family members mediating amino acid transport (SLC7A5, SLC1A5), a chemokine receptor (CXCR6), a cytokine receptor (IL21R), a cytokine (TGFB1), and fattyacid-binding protein (FABP5), a molecule critical for free fatty acid uptake and in return survival of skin CD8 þ T RM
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( Figure 2c) . All of these genes demonstrated high expression levels in the CD103 þ T RM . CD103 þ T RM expressed low levels of several factors mediating WNT pathway signaling (TCF7, WNT7A), a guanyl nucleotide exchange factor (RASGRP2), and ICAM2, an adhesion molecule regulating adhesion between immune cells.
To identify genes that may be specifically expressed by lung
, we compared the above identified T RM core signature with that of our previous report on lung CD8 þ T RM . 13 We found an overall strong resemblance between both signatures (Figure 2d) . Although blood CD4
þ and CD8 þ T cells are generally accepted to be very distinct from each other, these data indicate that the lung niche induces a similar transcriptional imprint on the two T-cell lineages and suggest that the mechanisms involved to retain CD4 þ and CD8 þ T cells in the lung tissue are alike. Only very few genes were uniquely upregulated by CD4 þ CD103 þ T RM . Among these were the lysosomal vesicle marker LAMP2 and transcriptional corepressor TLE. The complete list of genes, in alphabetical order, and the corresponding log 2 fold changes are listed in Supplementary Table S2 . As among the circulating subsets, the T EM appeared most closely related to the lung T RM , we focus on the comparison of lung T RM and blood T EM in the remainder of the article.
Differential expression of homing molecules by lung CD4 þ T RM CD4 þ T RM are anchored in the lung tissue. In mice, their persistence is mediated by specific adhesion molecules that prevent recirculation and allow migration in the tissue. 33, 34 Besides the expression of CD103, which helps T RM dock to E-cadherin in epithelia, 22, 23 lung CD4 þ CD103 þ T RM exhibited high mRNA levels of various other integrins and adhesion molecules reflecting this unique property of T RM (Figure 3a ).
Relative to circulating T EM , CD103
þ T RM demonstrated low mRNA levels for ICAM2 (also known as CD102) and high levels of ICAM1 (also known as CD54), a pattern associated with lymphocyte activation.
35 CD103
þ T RM also expressed high levels of the integrin VLA-1 (encoded by ITGA1). As T RM that express CD69 but lack CD103 have been described, 36 we also compared the protein expression of homing molecules between the lung-derived CD103 À CD69 þ T cells (referred to as CD103 À T RM ) and CD103 þ T RM . Protein expression of VLA-1 was mainly restricted to CD103 þ T RM , as only a part of the CD103 À T RM and very few of the peripheral T EM expressed VLA-1 ( Figure 3b) . Whereas CD97, G-proteincoupled receptor, is expressed by all T cells, increased expression levels of CD97 were found for the CD103 þ T RM and are also shared by lung CD8 þ CD103 þ T RM 13 and intestinal lamina propria CD8 þ T RM . 37 Chemokine receptors that distinguished lung CD103 þ T RM from peripheral T EM include CCR7, CXCR6, and CXCR3 ( Figure 3c ). Whereas downregulation of CCR7 impairs T-cell homing to lymph nodes, 38 expression of CXCR6 and CXCR3 is associated with T-cell recruitment to inflamed tissues. 39, 40 Elevated levels of these two chemokine receptors were confirmed at protein level for both CD103
þ T RM and CD103 À T RM subsets ( Figure 3d ). We also found both CD4 þ T RM subsets to express CCR5 protein (Figure 3d ), another chemokine receptor associated with lymphocyte recruitment during inflammation. 41 In summary, consistent with their unique location, lung CD4 þ T RM expressed specialized profiles of adhesion molecules and chemokine receptors that distinguish them from peripheral CD4 þ T cells.
Transcription factor expression by lung CD4 þ T RM T-cell differentiation and function are regulated by networks of transcription factors. For peripheral blood CD4 þ T cells, the T-box and RORgt transcription factors are known to drive T helper 1 (Th1) and Th17 cell function, respectively. 24 In mice, the synergistic downregulation of Eomesodermin (Eomes) and T-bet was demonstrated to be a requirement for the formation of CD8 þ T RM . 42 In addition, it has recently become appreciated that Blimp1 and Hobit (encoded by PRDM1 and ZNF683, respectively) regulate the programming of CD8 þ T RM in mice. 43 To investigate whether similar mechanisms underlie CD4 þ T RM formation in the human lungs, we analyzed the expression of these transcription factors. The levels of T-bet and Eomes mRNA transcripts were not elevated in CD103
þ T RM when compared with blood T EM cells (Figure 4a ). In addition, lung CD103
þ T RM transcript levels of PRDM1 and ZNF683 were slightly upregulated when compared with blood T EM . In line with mRNA levels, protein expression of T-bet and Eomes was intermediate to low in both CD103 þ and CD103 À T RM ( Figure 4b) . Furthermore, CD103
þ T RM lacked Hobit protein expression whereas a proportion of blood T EM expressed Hobit ( Figure 4b ). This is in accordance with our observation that the CD4 þ CD28 À T cells that form a subpopulation within the T EM compartment express high levels of Hobit. 44 We could not address Blimp1 protein expression because of the lack of reliable antibodies. To investigate whether CD4 þ CD103 þ T RM have a Th2, Th17, or regulatory transcriptional identity, we determined the expression of GATA-3, RORC, and FOXP3. The CXCR6  METRNL  PPARG  BCAR3  LMNA  MYO7A  JAG2  TRIB1  SLC7A5  EGR2  TOX2  GPR35  C1QC  EPAS1  ATP1B1  PDE4A  FABP5  BMF  MYADM  NAPSA  BATF  SLC1A5  SERP1NA1  PHLDA1  ACOT7  TNFRSF1B  TLE3  PDCL3  TGFBI  ITPRIPL2  IL21R  SYAP1  SPATA2L  DSE  MAP1LC3A  OASL  TOB2  SQLE  CSNK1D  NUSAP1  RAB35  H2AFX  NIPA2  RBBP8  FBRSL1  CYP27A1  FOSL2  MTHFD2  EDARADD  EIF6  FAM177A1  HNRNPAB  C12orf44  MAP2K3  TGIF2  NR3C1  TMEM115  EHD1  TOR1B  SRGN  ADIPOR2  PPP1R2P9  TCF7  PFN2  MAGEE1  PFKFB4  NOSIP  ZYG11B  CDC25B  PPFIBP2  CCDC104  PYROXD2  SVIL  ADD3  TSPAN1B  TCEA3  RASGRP2  XIST  C2orf89  TSHZ2  DPEP2  LTB  WNT7A  SESN1  TBC1D4  LEF1  FAM153A  VIPR1  DENND5A  BEX2  PLAC8  PRKCA  IFI44L  ICAM2  S1PR1 SELL MAL Figure S3a,b) . In search of other transcription factors that may be involved in the regulation of lung CD4 þ CD103 þ T RM , we identified a set of transcription factors among the core signature described above ( Figure 2) . Interestingly, we found CD103 þ T RM to express both BATF and IRF4, transcription factors required for the maintenance of T RM in adipose tissue 45 
þ T RM core signature was determined as the genes differentially expressed between lung CD103 þ T RM and blood
, and T N CD45RA þ CD27 þ (blue) (based on significance with a false-discovery rate (FDR) of o0.05). The core signature was defined as the genes differentially expressed between the T RM and all three blood populations, shown in the middle of the Venn diagram. (b) The expression of selected genes (S1PR1, SELL, CCR7, ITGAE, CTLA4, ICOS) was compared between CD103 þ T RM (black circle) and blood (Figure 4d) . Furthermore, increased transcript levels were observed for the transcriptional regulator RBPJ, central to Notch signaling, and the Notch ligand JAG2 (Figure 4d) . Moreover, we found increased expression of ZEB2, encoding a transcription factor regulated by Notch signaling in mice. MSC  ZEB2  PBX4  PPARG  EPAS1  EGR2  MAMLD1  NAB1  FOSL2  BCOR  ZNF282  ZNF250  BCL3  IRF4  BRD1  TRERF1  ADRM1  FOXD2  TLE3  SMAD7  FOXO1  FOXD1  RBM14  SERTAD1  RBPJ  EYA3  ADNP  PLAGL2  TGIF2  ZNF18  ZNF333   ZNF32  DBP  CCDC59  SSBP3  ANKRA2  ING3  TCF7  KLF12  ZNF91  NR3C2  ZNF101  LEF1  TCEA3   ZBTB25 To explore the functional properties of the CD4 þ CD103 þ T RM we determined the expression of inhibitory molecules often associated with T-cell exhaustion. CD4 þ CD103 þ T RM expressed a variety of inhibitory checkpoint molecules, such as PDCD1 (encoding for PD-1), CTLA4, and LAG3 (Figure 5a ). Protein expression was confirmed for PD-1 and CTLA4 and although we did not find 2B4 (CD244) to be differentially expressed at mRNA level, all CD4 þ CD103 þ T RM expressed high 2B4 protein, whereas only a portion of circulating T EM did (Figure 5b) . The geometric mean fluorescence intensity for PD-1 was not increased in the CD4 þ CD103 þ T RM either (Supplementary Figure S4a) . To assess whether the disease state affects the expression of PD-1 on blood T EM , we determined the expression in a cohort of healthy age-matched donors. Similar PD-1 levels were observed between patient and donor blood T EM (Supplementary Figure S4b) . This suggests that the T RM are chronically or intermittently activated and thus potentially exhausted. Therefore, next we investigated the responsiveness of these cells in vitro.
exhibit rapid and polyfunctional cytokine responses
Ideally T RM should be poised for rapid effector function upon activation as they are perceived as part of the first line of defense upon secondary infections. To investigate this role in lung CD4 þ CD103 þ T RM , we analyzed the transcript levels of various chemokines and effector molecules. Relative to bloodderived T EM , lung CD4 þ CD103 þ T RM expressed high transcript levels for genes encoding for several chemokines and cytotoxic molecules (Figure 6a) . We found differentially high expression of CCL4, CXCL16, and XCL1 and similar trends for CCL3, CCL5, and CCL18. These elevated mRNA levels may serve to allow rapid translation and secretion to attract and position auxiliary immune cells, a key function of T RM , following infection. 5, 48, 49 The high expression of CXCL16 may be of special interest as its receptor (CXCR6) was found to be highly expressed on lung CD8 þ T RM . 13 High expression of XCL1 was also described for lung CD8 þ T RM 13 and is shown to mediate cytotoxic immune function. 50, 51 Effector and cytotoxic molecules for which transcript levels were elevated in CD4 þ CD103 þ T RM include IFNG, GZMA, GZMB, and PRF1 (Figure 6a) . Such deployment-ready mRNA suggests an alert state and readiness to respond to incoming pathogens and prevent the spreading of infections. Indeed, when activated with aCD3/aCD28, CD4
þ CD103 þ T RM demonstrated accelerated kinetics for IFNg production when compared with blood-derived CD45RA À memory T-cells (T M ) (Figure 6b) protein, we set out to investigate whether the preformed transcript provides the T RM with a kick start. To do so, we pretreated lung and blood T cells with Actinomycin D (ActD), blocking de novo transcription, followed by T-cell receptor stimulation. In this way the protein produced has to be derived from the preformed transcript. After 2 h of stimulation, the non-ActD-treated CD103 þ T RM produced IFNg, whereas the ActD-treated CD103 þ T RM produced significantly less (Figure 6c) . Thus, the T RM appear to mainly rely on de novo transcription for their superior cytokine production.
Potency of effector T-cell function is defined as the ability to produce multiple cytokines simultaneously. This polyfunctionality is gradually lost upon T-cell exhaustion. 52, 53 We calculated the percentage of cells that produced at least one cytokine, referred to as the responders (Figure 6d ). As such, the percentage of responders among CD103 þ T RM cells was 55%, more than twice as high as the percentage of responders among the blood-derived memory T cells. The percentage of polyfunctional responders was significantly higher in the CD103 þ T RM population (31%) when compared with blood CD45RA À T M (7%) (Figure 6d and Supplementary Figure  S5b) . In summary, we showed that although CD4 þ CD103 þ T RM expressed several inhibitory molecules associated with T-cell exhaustion, these cells were more than capable of rapidly producing a multitude of cytokines upon stimulation and thus do not correspond with their ''exhausted'' phenotype.
DISCUSSION
Here we analyzed the molecular and functional profiles of the previously uncharacterized, but abundantly present, CD4
þ T RM population in the human lungs. We addressed several properties of CD4 þ T RM demonstrating their adaptation to the tissue niche, including the expression of a wide range of chemokine receptors and adhesion molecules and a strictly controlled effector mechanism designed to effectively mediate pathogen control while safeguarding the fragile lung environment. T RM are traditionally defined by the expression of CD103 and CD69, the latter molecule blocking tissue egress by the inhibition of S1PR1 function. 21 Recently, these criteria have been challenged, as CD69 þ cells were found to recirculate 31 and CD69 À cells were found to be resident. 54 In support of this, we demonstrated that lung CD4 þ CD69 À T cells are composed of effector and memory cells, whereas circulating CD4 þ T cells mainly consist of naive and central memory T cells. Thus the CD4 þ CD69 À T cells are not in strict equilibrium with circulating CD4 þ T cells. The characterization of T RM by the expression of CD103 remains undisputed, as this molecule is important to dock T cells to the epithelial E-cadherin. 22, 23, 55, 56 We therefore identified lung CD4 þ T RM cells by the expression of CD103 and found these cells to clearly express a distinct mRNA expression profile when compared with circulating CD4 þ T cells. Using classical flow cytometric analysis, we showed that at least three different lung CD4 þ T-cell subsets could be established based on the expression of CD69 and CD103. More detailed phenotyping revealed a previously unrecognized complexity of the CD4 þ T RM compartment in the lung. For example, the expression of VLA-1, CXCR6, and even inhibitory molecules, such as 2B4, did not strictly associate to any of the three populations as addressed by the conventional phenotyping method. Future single-cell approaches may deal with this caveat of population-averaged measurements in conventional transcriptome analysis experiments. A large body of evidence indicates the indispensable role of CD8 þ and CD4 þ T RM in protecting the lung against respiratory pathogens.
1,2,10,11,42,57 For this purpose, T RM must be equipped to immediately react when a pathogen enters the lungs. However, such responses need to be kept in check, as excessive cytotoxicity may damage the fragile lung architecture and compromise its vital function. We previously published that human CD8 þ T RM are specifically programmed for this tightly regulated effector function. 13 In line with this, others have shown that when lung T RM function is not effectively controlled there is an increased correlation with inflammatory diseases of the airway, such as asthma. 58 Here, we describe that similar mechanisms may apply to the lung CD4 þ T RM compartment, as we found a high degree of resemblance of differentially expressed genes that regulate T-cell effector function between the CD8 þ and CD4 þ T RM . This suggests that the lung environment is important for the transcriptional and functional identity of lung T RM , regardless of their lineage. CD4 þ CD103 þ T RM also constitutively expressed mRNA for various effector molecules potentially underlying the rapid response to T-cell receptor stimulation. In addition, we demonstrated that not only the magnitude, but also the quality of the effector response is different when compared with blood T cells, as the T RM exhibited a higher degree of polyfunctionality. Although CD4 þ CD103 þ T RM showed elevated transcript levels of IFNg, suggesting that the rapid production of IFNg is due to the lack of transcriptional delay, our data suggest that this is not entirely the case. We showed that CD4 þ CD103 þ T RM require active transcription to produce effector cytokines, as the cytokine production was diminished upon blockade of de novo transcription. This rather proposes that the IFNg locus is readily accessible in the T RM . Simultaneously, the T RM do not produce IFNg protein until stimulated, indicating that the T RM are poised for effector function. This may be elementary to the core tasks of CD4 þ T RM , as IFNg is essential for the swift recruitment of auxiliary immune cells to the site of infection, 49, 59 protection against respiratory viruses, 57 as well as the formation of CD8 þ CD103 þ T RM in the lung. 5 At the same time, although rapid effector function of T RM is desirable when combating incoming pathogens, release of effector molecules needs stringent regulation to prevent excessive immunopathology to the fragile lung tissue. Next to the strict translational control, as a second potential safety mechanism, CD4 þ T RM expressed high levels of various inhibitory checkpoint molecules. It is likely that in vivo these inhibitory molecules depend on their ligands to limit activation of the CD4 þ T RM . Controversially, such receptors indicate chronic or intermittent activation and therefore potential exhaustion, especially in the context of tumor tissues. 60 As lung CD4 þ CD103 þ T RM possessed the capacity to robustly and polyfunctionally respond to T-cell receptor stimulation, our data provide more insights regarding T-cell exhaustion. Furthermore, it indicates that tissue context should be considered when interpreting T-cell dysfunction on the basis of checkpoint molecule expression.
A large proportion of the CD4 þ T cells in the lungs expressed the chemokine receptor CXCR6. As lung epithelial cells constitutively express the CXCR6 ligand CXCL16, this axis may be crucial for homing of T cells to the lung tissue. 61 This mechanism may also be more generic, as liver-resident natural killer (NK) and NK T cells, as well as lymphoid tissue-derived NK cells express CXCR6. [62] [63] [64] In addition, CD4 þ T RM populations uniformly expressed CXCR3 and CCR5, the chemokine receptors that are important for T-cell recruitment to inflamed lungs. [39] [40] [41] CXCR3 is also more broadly described to regulate T-cell recruitment to sites of inflammation or disease. [65] [66] [67] [68] [69] The preferential expression of the integrin VLA-1 by CD4
þ CD103 þ T RM could account for their survival and accumulation in the vicinity of the lung epithelium, as was previously shown for mouse CD8 þ and CD4 þ T RM . 34, 70 Simultaneously, VLA-1 expression discriminates CD8 þ T RM with high cytotoxic potential specifically localized in the epidermis of human skin. 71 We have previously shown that CD8 þ CD103 þ T RM line the epithelium of the human lung. 72 It has recently been shown that CD4 þ and CD8 þ T RM localize differently in the lungs of mice. CD4 þ T RM cluster in bronchusassociated lymphoid tissue structures, whereas CD8 þ T RM form niches around areas of tissue damage. 73 Similar structures were observed in the skin, female reproductive tract, and intestines. 31, 74, 75 As to whether similar clusters exist in the human lungs needs further investigation.
Recently, we demonstrated that Notch signaling is required for the maintenance of lung CD8 þ CD103 þ T RM . 13 More recently, similar Notch signatures were identified in CD8 þ T cell with T RM like features in lung cancer. 76 Our data suggest that Notch may play a similar role in the regulation of lung CD4 þ T RM . Moreover, the immunomodulatory role of Notch signaling in the lungs may not be restricted to T cells, as other studies demonstrated Notch dependency of lung dendritic cells and macrophages. 77, 78 Notch is a surface receptor that, upon stimulation by Delta-like ligands, acts as a transcriptional activator. 79 Consequently, tissue environmental-induced Notch signaling can directly lead to expression of mRNA encoding for Notch target genes, including IFNg. 80 This type of mechanism demonstrates the perfect adaption of T RM to the lung environment. In addition, as pharmaceutical inhibitors of Notch signaling are available, this offers ways for therapeutic intervention when T RM mediate pathology in the airways. CD4 þ T RM expressed low to intermediate levels of T-bet and Eomes. The downregulation of these two transcription factors is necessary for the formation of CD8 þ T RM , and thus similar mechanisms may be important for CD4 þ T RM . Strikingly, we did not detect protein expression of the Hobit (encoded by ZNF683) transcription factor that serves as an ontogenic regulator of T RM formation. 43 These results appear counterintuitive, as we found CD4 þ CD103 þ T RM to express high mRNA levels encoding for this transcription factor that is in contrast to our previous findings in circulating T cells. 44, 81 Our data do not exclude a possible role of Hobit for the formation of human lung CD4 þ T RM and as its expression was found to be regulated by stimulation in NKT cells, 82 more research is required.
Overall, our work strengthens the fundamental understanding of CD4 þ T cells residing in the human lungs. This knowledge will create opportunities for novel therapeutic manipulation of CD4 þ T RM in terms of vaccine design and immunotherapy. Ideally, these cells could be harnessed to boost the efficacy of vaccine regimens. In addition, as T RM can also contribute to local pathology, 58 identifying novel targets can enable selective deletion of these cells for therapeutic intervention.
METHODS
Subjects. Lung tissue samples were obtained from a total of 85 patients with an average age of 63.9 years. In all, 70 patients underwent lobectomy for a peripheral primary lung tumor and 15 received a lung transplantation due to end-stage pulmonary disease. The exclusion criteria included history of asthma or a recent lower respiratory tract infection. The patients did not receive systemic immunosuppressive drugs, chemotherapy, or radiotherapy. Lung material from six lobectomy patients was used for the microarray, of whom two had normal lung function and four had mild to moderate chronic obstructive pulmonary disease. For the other assays samples were chosen at random. The lobectomy patients were recruited from the Academic Medical Centre (AMC), Amsterdam, The Netherlands, Tergooi Hospitals, Hilversum, The Netherlands, and Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, The Netherlands, and the transplantation patients were recruited from University Medical Centre Groningen, Groningen, The Netherlands. Sanquin Blood Supply Foundation, Amsterdam, The Netherlands, supplied the buffy coats of donors used as healthy controls. The age and sex of the healthy donors is unknown. Study approval. Written informed consent was given by all of the patients and donors before inclusion into the study. The ethical review board of the AMC and the METC/CCMO of the OLVG approved the study under the MEC-U number NL52453.100.15 according to the Declaration of Helsinki. All mice were used in accordance of institutional and national animal experimentation guidelines.
Isolation of mononuclear cells from peripheral blood and lung tissue. Peripheral blood mononuclear cells were isolated from heparinized peripheral blood samples with standard density gradient techniques. For the lung material, after the lobectomy the pathologist cuts off a piece of peripheral normal-looking lung tissue farthest away from the tumor. The lung mononuclear cells were isolated from the tissue as previously described. 4, 83 In short, the tissue was sliced into 1 mm pieces using a McIlwain tissue chopper (Loughborough, UK) and incubated at 37 1C in digestion medium (RPMI with 20 mM Hepes, 15% fetal calf serum, and 50 U ml À 1 DNAse type I (Sigma-Aldrich, Zwijndrecht, the Netherlands)). The tissue pieces were dried with sterile gauze and incubated for 60 min with medium and collagenase type I or 4 (300 U ml À 1 ; Worthington, The Hague, the Netherlands) at 37 1C while shaking. The digested tissue was passed through a flowthrough chamber to achieve a cell suspension. To isolate mononuclear cells from the cell suspension, standard density gradient techniques were used. The lung mononuclear cell and peripheral blood mononuclear cell samples were cryopreserved in liquid nitrogen until further analysis.
Lungs of the mice were cut into small pieces and digested with Collagen type I (750 U ml À 1 ; Gibco, Landsmeer, the Netherlands) and DNAse type I (0.31 mg ml À 1 ; Roche, Woerden, the Netherlands) in Iscove's modified Dulbecco's medium for 30 min at 37 1C, followed by filtration. To isolate mononuclear cells from the cell suspension, standard density gradient techniques were used.
Flow cytometric cell sorting. For gene expression analysis, peripheral blood mononuclear cells and lung mononuclear cells were sorted based on different combinations of the following antibodies: CD27, CD45RO, CD103, CD45RA, CD3, CD8, CD4, and CD69.
RNA isolation, amplification, labeling, and hybridization. RNA from the sorted cells was isolated using the Nucleospin RNA XS and Nucleospin RNA II kit (Macherey-Nagel) in accordance with the manufacturer's protocols. Amplification, labeling, hybridization, and data extraction were done by ServiceXS (Leiden, The Netherlands). Hybridization was performed on to Whole Human Genome HT12-Microarrays (Illumina, Leiden, the Netherlands) and the Illumina iScan array scanner was used to scan the arrays. Illumina GenomeStudio v2011.1 software was used to retrieve the data. Because of low average signal after the hybridization, four of the microarrays were excluded.
Microarray analysis. Analyses were carried out with packages from Bioconductor in the statistical software package R (version 3.0.0, Auckland, New Zealand). Normexp-by-control background correction, quantile normalization, and log 2 transformation 84 were performed on the Illumina sample and control probe profiles using the limma package (version 3.16.8). Using the arrayQualityMetrics package (version 3.16.0, Bioconductor Buffalo, NY) one outlier array was detected. This array was discarded and the data were renormalized. Technical replicate arrays were averaged. Only probes detected (detection P value o0.05) on at least one array were included in the differential expression analysis. Gene-wise linear models were fitted using the limma package. A consensus intrapatient correlation was estimated for measurements on the same subject (function 'duplicateCorrelation', package limma) and included in the linear model fit. Differential gene expression between the different conditions was assessed via a moderated t-test. Resulting P values were corrected for multiple testing using the Benjamini-Hochberg false discovery rate. The illuminaHumanv4.db package (version 1.18.0) was used to update the probe annotation provided by Illumina. The microarray data have been deposited in the NCBI (National Center for Biotechnology Information) Gene Expression Omnibus (GEO) in a MIAME compliant format and are accessible under GEO Series accession number GSE103527.
Quantitative PCR. For validation of the microarray data, RNA was isolated from the sorted samples using Invisorb RNA isolation kit (Invitek, Berlin, Germany) or Trizol reagent (Invitrogen, Landsmeer, the Netherlands). Complementary DNA was synthesized using RevertAID H Minus Reverse Transcriptase (Thermo Scientific, Landsmeer, the Netherlands) and random primers (Invitrogen) or poly dT oligos (Invitrogen). Quantitative PCR analysis was performed in duplicate using Power SYBR Green (Applied Biosystem, Landsmeer, the Netherlands) with StepOnePlus Real-Time PCR system (Applied Biosystem). The gene expression was normalized to S18. The primers used are listed in Supplementary Table S3 .
Flow cytometry analysis. Human peripheral blood mononuclear cells or lung mononuclear cells were labeled with combinations of the following antibodies: anti-CD4, anti-CD3, anti-CD8, anti-CD27, anti-CD45RA, anti-CD69, anti-CD103, anti-CD49a, anti-CXCR6, anti-CXCR3, anti-CCR5, anti-CD28, anti-CCR7, anti-PD-1, and anti-2B4. Near-infrared fixable dye (Invitrogen) was used to exclude dead cells from the analysis. For intracellular staining the following antibodies were used: anti-CTLA4, anti-Hobit, anti-Eomes, anti-T-bet, antiIFNg, anti-interleukin-2, and anti-tumor necrosis factor-a. To stain for Hobit a labeled secondary anti-IgM was used. The cells were labeled according to the manufacturer's instructions. For the intracellular staining the cells with fixed and permeabilized using the Foxp3/ Transcription Factor Staining kit (eBioscience, Landsmeer, the Netherlands). For analysis of the mouse T RM , the lung cells were stained with the following fluorochrome-conjugated antibodies: anti-CD3, anti-CD4, anti-CD44, anti-CD62L, anti-CD103, anti-CD69, and CD1d tetramer at 4 1C for 30 min. Near-infrared fixable dye (Invitrogen) was used to exclude dead cells from the analysis. The cells were labeled according to the manufacturer's instructions. For the intracellular staining with Foxp3, cells were fixed and permeabilized using the Foxp3/Transcription Factor Staining kit (eBioscience). All samples were measured in phosphate-buffered saline 0.5% fetal calf serum with a LSR Fortessa (BD, Temse, Belgium) and the analysis was performed using FlowJo Version 10 software (Temse, Belgium). See Supplementary Table S4 for the full list of antibodies used in this paper.
In vitro stimulation assays. Cytokine production by the CD4 þ T cells was determined by incubating the cells with plate-bound aCD3 (HIT3A; eBioscience) and soluble CD28 (s.28; CLB, De Rijp, the Netherlands) for 6 h at 37 1C in the presence of Brefeldin A (eBioscience). For the experiments using ActD, CD4
þ T cells were isolated using MACS (Miltenyi Biotec, Leiden, the Netherlands). Where indicated, T cells were pretreated with ActD (Sigma-Aldrich) for 30 min at 37 1C before activation with plate-bound aCD3 (HIT3A; eBioscience) and soluble CD28 (s.28; CLB) for 2 h at 37 1C in the presence of Brefeldin A (eBioscience).
Statistics. To determine the significance of our flow cytometry results we used one-way analysis of variance and Holm-Sidak multiple comparisons test using GraphPad Prism 6 (La Jolla, CA). To analyze the significant of the mouse T RM , paired T-test was used. Two-way analysis of variance and Tukey's multiple comparisons test was used to determine the significance of the in vitro functional assays. The P value of o0.05 was considered statistically significant (*Po0.05; **Po0.01; ***Po0.001; ****Po0.0001). Gene-E v3.0.206 (Cambridge, MA) was used to make the heat maps for which the mean and maximum values for each row was used to generate the heat map colors.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
